Drug 1 autoimmune disease companion diagnostic - Sengenics
Alternative Names: Autoimmune Disease Drug 1 companion diagnostic - SengenicsLatest Information Update: 28 Aug 2023
At a glance
- Originator Sengenics
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 28 Aug 2023 No recent reports of development identified for preclinical development in Autoimmune-disorders(Diagnosis) in Singapore
- 25 Jul 2019 Preclinical trials in Autoimmune disorders (Diagnosis) in Singapore (unspecified route)
- 12 Jul 2019 Sengenics and the Foundation for the National Institutes of Health collaborate to develop diagnostics, companion diagnostics and therapeutics for Autoimmune diseases